- Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines
Monika M. Kutyna et al, 2023, International Journal of Molecular Sciences CrossRef - Modulation of the Endothelin System in Colorectal Cancer Liver Metastasis: Influence of Epigenetic Mechanisms?
Mohamed R. Mahdi et al, 2020, Frontiers in Pharmacology CrossRef - Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase
Mika Hosokawa et al, 2021, Biochemical and Biophysical Research Communications CrossRef - Treatment effects of oxaliplatin combined with gemcitabine on colorectal cancer and its influence on HMGB1 expression
Shuangshuang Wen et al, 2016, Oncology Letters CrossRef - Cell signaling and cancer: a mechanistic insight into drug resistance
Munmun Panda et al, 2019, Molecular Biology Reports CrossRef - Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
Nassiba Taib et al, 2023, Journal of Translational Medicine CrossRef - In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells
Manali Patki et al, 2021, Experimental Cell Research CrossRef - Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic
Khushboo Agrawal et al, 2018, Pharmacology & Therapeutics CrossRef - Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine
Mika Hosokawa et al, 2019, Biochemical and Biophysical Research Communications CrossRef - HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells
Bhuvanesh Sukhlal Kalal et al, 2019, Medical Sciences CrossRef - Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
Gonzalo Lopez et al, 2017, PLOS ONE CrossRef - Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
Kristína Šimoničová et al, 2022, Drug Resistance Updates CrossRef